You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
| Title |
Chemotherapeutic errors in hospitalised cancer patients: attributable damage and extra costs
|
|---|---|
| Published in |
BMC Cancer, November 2011
|
| DOI | 10.1186/1471-2407-11-478 |
| Pubmed ID | |
| Authors |
Florence Ranchon, Gilles Salles, Hans-Martin Späth, Vérane Schwiertz, Nicolas Vantard, Stéphanie Parat, Florence Broussais, Benoît You, Sophie Tartas, Pierre Jean Souquet, Claude Dussart, Claire Falandry, Emilie Henin, Gilles Freyer, Catherine Rioufol |
| Abstract |
In spite of increasing efforts to enhance patient safety, medication errors in hospitalised patients are still relatively common, but with potentially severe consequences. This study aimed to assess antineoplastic medication errors in both affected patients and intercepted cases in terms of frequency, severity for patients, and costs. |
X Demographics
The data shown below were collected from the profiles of 14 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Spain | 2 | 14% |
| Venezuela, Bolivarian Republic of | 1 | 7% |
| Argentina | 1 | 7% |
| El Salvador | 1 | 7% |
| Unknown | 9 | 64% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 12 | 86% |
| Practitioners (doctors, other healthcare professionals) | 1 | 7% |
| Scientists | 1 | 7% |
Mendeley readers
The data shown below were compiled from readership statistics for 133 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United Kingdom | 2 | 2% |
| Brazil | 2 | 2% |
| Spain | 1 | <1% |
| Unknown | 128 | 96% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Master | 16 | 12% |
| Researcher | 14 | 11% |
| Student > Ph. D. Student | 13 | 10% |
| Student > Postgraduate | 10 | 8% |
| Student > Bachelor | 10 | 8% |
| Other | 31 | 23% |
| Unknown | 39 | 29% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 26 | 20% |
| Pharmacology, Toxicology and Pharmaceutical Science | 26 | 20% |
| Nursing and Health Professions | 9 | 7% |
| Chemistry | 4 | 3% |
| Social Sciences | 4 | 3% |
| Other | 16 | 12% |
| Unknown | 48 | 36% |
Attention Score in Context
This research output has an Altmetric Attention Score of 10. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 15 March 2015.
All research outputs
#3,115,808
of 23,128,387 outputs
Outputs from BMC Cancer
#695
of 8,394 outputs
Outputs of similar age
#17,692
of 143,902 outputs
Outputs of similar age from BMC Cancer
#5
of 97 outputs
Altmetric has tracked 23,128,387 research outputs across all sources so far. Compared to these this one has done well and is in the 86th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 8,394 research outputs from this source. They receive a mean Attention Score of 4.3. This one has done particularly well, scoring higher than 91% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 143,902 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 87% of its contemporaries.
We're also able to compare this research output to 97 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 95% of its contemporaries.